BCR and chronic myelogenous leukemia, BCR-ABL1 positive: This mechanism was utilized for the conditional activation of PKR-mediated cell death via a duplex consisting of the Bcr/Abl fusion oncogene (typical for chronic myelogenous leukemia) and an exogenous designed cognate antisense strand [35].